
Progress in the personalized medicines sector and the adoption of new avenues for biotechnology applications are boosting the biotech industry. However, concerns such as economic slowdowns and geopolitical risks might hamper its growth.
Therefore, while I think quality biotech stocks Gilead Sciences, Inc. (GILD) and Regeneron Pharmaceuticals, Inc. (REGN) might be solid buys, Titan Pharmaceuticals, Inc. (TTNP) might be best avoided.